The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides.
- 1State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Key Laboratory of Chemical Biology (Ministry of Education), Shandong Basic Science Research Center (Pharmacy), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
- 2Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266000, China.
Abstract
Mesobuthus martensii, the source species of the traditional Chinese medicine "Quanxie", has long been utilized for its therapeutic properties. Venom peptides are recognized as the major active molecular basis of these pharmacological activities. Despite this, their development as therapeutic agents remains poorly explored. In this study, we performed an integrated multi-omics investigation to systematically explore the venom peptides of Mesobuthus martensii. We generated a chromosome-level genome assembly of Mesobuthus martensii using third-generation sequencing technologies, yielding a genome size of 1.08 Gb with a contig N50 of 46.46 Mb. Integrated genomic and transcriptomic analyses led to the identification of 51 putative novel venom peptide candidates. From the broader venom peptide set, five lysine- and arginine-rich candidates were selected for recombinant expression and functional characterization. Functional evaluation revealed that MmTX67, MmTX106 and MmTX126 modulated coagulation-related parameters in vitro, with MmTX106 further demonstrating the most pronounced antithrombotic effect in vivo. Collectively, these findings provide novel insights into the genetic basis of bioactive substances in "Quanxie" and highlight MmTX106 as the most promising antithrombotic candidate, while providing a molecular foundation for further evaluation of other scorpion venom-derived peptide candidates.
Related
- Identification and expression analysis of antibacterial peptides from venom of the scorpion Mesobuthus martensii
- Chromosome-level genome assembly of Falcataria falcata provides insights into ancient polyploidy and duplicate gene evolution in Fabaceae
- Chromosome-number diversity and evolution in Nitrariaceae: a critical synthesis of cytological, genome-size and genomic evidence
- The chromosome-level annotated reference genome MakAnk1.0 reveals a putative signature of selection for long horns and provides insights into the demographic history of Ankole cattle
- Genomic evidence for Z-W differentiation in Pacific saury (Cololabis saira) and sex-chromosome diversity in Beloniformes
BibTeX
@article{liu2026chromosomelevel,
title = {{The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides.}},
author = {Daixi Liu and Qianhui Zeng and Yifei Sun and Changfen Li and Yanjun Song and Zhuo Shang and Kunlong Li and Hongjie Zhu and Feng Li and Chuanbin Shen and Jianhua Ju},
journal = {Pharmaceutical science advances},
year = {2026},
month = sep,
doi = {10.1016/j.pscia.2026.100149},
url = {https://europepmc.org/article/MED/42898872},
note = {CC BY},
}
RIS
TY - JOUR
TI - The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides.
AU - Daixi Liu
AU - Qianhui Zeng
AU - Yifei Sun
AU - Changfen Li
AU - Yanjun Song
AU - Zhuo Shang
AU - Kunlong Li
AU - Hongjie Zhu
AU - Feng Li
AU - Chuanbin Shen
AU - Jianhua Ju
PY - 2026
DA - 2026/09/06
JO - Pharmaceutical science advances
DO - 10.1016/j.pscia.2026.100149
UR - https://europepmc.org/article/MED/42898872
AB - Mesobuthus martensii, the source species of the traditional Chinese medicine "Quanxie", has long been utilized for its therapeutic properties. Venom peptides are recognized as the major active molecular basis of these pharmacological activities. Despite this, their development as therapeutic agents remains poorly explored. In this study, we performed an integrated multi-omics investigation to systematically explore the venom peptides of Mesobuthus martensii. We generated a chromosome-level genome assembly of Mesobuthus martensii using third-generation sequencing technologies, yielding a genome size of 1.08 Gb with a contig N50 of 46.46 Mb. Integrated genomic and transcriptomic analyses led to the identification of 51 putative novel venom peptide candidates. From the broader venom peptide set, five lysine- and arginine-rich candidates were selected for recombinant expression and functional characterization. Functional evaluation revealed that MmTX67, MmTX106 and MmTX126 modulated coagulation-related parameters in vitro, with MmTX106 further demonstrating the most pronounced antithrombotic effect in vivo. Collectively, these findings provide novel insights into the genetic basis of bioactive substances in "Quanxie" and highlight MmTX106 as the most promising antithrombotic candidate, while providing a molecular foundation for further evaluation of other scorpion venom-derived peptide candidates.
SN - 2773-2169
ER -